Curanex Pharmaceuticals Inc Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four
Curanex Pharmaceuticals Inc (CURX) had Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four of $43.38 thousand as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour · last filed 2026-05-14
- 2026-03-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $43.38K.
- 2025-12-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $61.08K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four |
|---|---|
| 2026-03-31 | $43.38K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $61.08K 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |